ID: ALA5269437

Max Phase: Preclinical

Molecular Formula: C10H15NO4

Molecular Weight: 213.23

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](O)C12NC(=O)[C@H](C)[C@@H]1OC2=O

Standard InChI:  InChI=1S/C10H15NO4/c1-4(2)6(12)10-7(15-9(10)14)5(3)8(13)11-10/h4-7,12H,1-3H3,(H,11,13)/t5-,6+,7+,10?/m1/s1

Standard InChI Key:  FWPWHHUJACGNMZ-OEUIFBLYSA-N

Associated Targets(Human)

Proteasome Macropain subunit MB1 2451 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 213.23Molecular Weight (Monoisotopic): 213.1001AlogP: -0.57#Rotatable Bonds: 2
Polar Surface Area: 75.63Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.38CX Basic pKa: CX LogP: 0.09CX LogD: 0.09
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.60Np Likeness Score: 1.48

References

1. Song R, Qiao W, He J, Huang J, Luo Y, Yang T..  (2021)  Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.,  64  (6.0): [PMID:33656892] [10.1021/acs.jmedchem.0c01640]

Source